Medication info

Lozasca Tablet 5/50 Milligrams

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Losartan Potassium›50mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Korea Biochem Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
For domestic use - 30 tablets/bottle [for domestic use], for export - 30 tablets/PTP [10 tablets/PTP x 3]
Approval status
Approval withdrawn

MFDS item code 201504050 · Approved 2015.06.19

This product's status changed to Approval withdrawn on 2025.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective circulating blood volume: Administration of this medicine is not recommended for a small number of patients with reduced intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or above, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, administration is not recommended.

Ingredients

Manufacturer
Korea Biochem Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for the initial treatment of patients with essential hypertension whose blood pressure is difficult to control with either amlodipine or losartan alone, and for patients with stage 2 hypertension who need a combination medication to reach their treatment target blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective circulating blood volume: Administration of this medicine is not recommended for a small number of patients with reduced intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or above, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, administration is not recommended.

Precautions

This drug may cause serious harm to the fetus, especially in the second and third trimesters of pregnancy, and should be discontinued immediately if pregnancy is confirmed. Taking this medication during pregnancy can lead to severe issues such as impaired fetal kidney function, decreased amniotic fluid, and craniofacial deformities. Women who may become pregnant should avoid this medication and it must not be used during pregnancy. Patients with reduced effective blood volume, such as those taking diuretics, should stabilize their condition before taking this medication and it is advisable not to administer this drug. Patients with hypersensitivity to any of the ingredients, severe liver dysfunction, severe aortic stenosis, or in a state of shock should not take this medication. Due to the blood pressure-lowering effects, dizziness or drowsiness may occur, and caution should be exercised when engaging in potentially dangerous activities such as working at heights or driving. This medication should be used with caution in patients with impaired kidney function or hyperkalemia, and potassium levels and kidney function should be regularly monitored through blood tests. Caution is also needed when used in conjunction with other antihypertensive agents due to the potential for enhanced blood pressure-lowering effects. Taking this medication with grapefruit juice may excessively increase its effects, so co-administration should be avoided. Nursing women are advised not to take this medication, and it is not recommended for children or adolescents under 18 years of age as safety and efficacy have not been established. In case of overdose, severe hypotension and increased heart rate may occur, necessitating immediate contact with a medical institution to receive appropriate treatment. Medications should be stored out of reach of children, and it is advisable not to transfer them to other containers.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb contraction
  • craniofacial dysmorphism
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 178 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • muscle weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • increased urinary frequency
  • fatigue
  • edema
  • vasculitis
  • hypertonicity
  • sensory loss
  • dysesthesia
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • diarrhea
  • loose stools
  • skin erythema
  • papular rash
  • dizziness
  • warmth sensation
  • reduced glucose tolerance
  • weakness
  • muscular cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • swelling
  • abdominal pain
  • angioedema
  • skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • rigid muscle
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • reduced libido
  • memory impairment
  • migraine
  • irritability
  • panic disorder
  • sleep disorders
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • pulmonary congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste distortion
  • tinnitus
  • reduced vision
  • nocturia
  • urethral infection
  • dry cough
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver dysfunction
  • fatigue
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • increased ALT
  • elevated serum creatinine
  • elevated liver enzymes
  • loss of consciousness
  • shock symptoms
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, thus it should be stored in a tightly sealed container. It is also advisable to keep it at room temperature, ideally between 1°C and 30°C. Proper storage can help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

For domestic use - 30 tablets/bottle [for domestic use], for export - 30 tablets/PTP [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.